IBEX Ltd (IBEX) stock
IBEXNasdaqServices-Computer Processing & Data PreparationFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/306% below fair value
$56.92+2.05 (+3.74%)
Close on Nov 13, 2026Market cap $755.82MP/E 17.2Yield –
IBEX EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
IBEX's EPS for the twelve months ending Sep 30, 2026 was $3.30, up 18.7% year over year. For fiscal 2026 it was $3.13, up 32.6% from the year before. The highest annual figure on record is $3.13 in fiscal 2026.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $3.13 | +32.6% |
| FY2025 | Jun 30, 2025 | $2.36 | +28.3% |
| FY2024 | Jun 30, 2024 | $1.84 | +10.2% |
| FY2023 | Jun 30, 2023 | $1.67 | +45.2% |
| FY2022 | Jun 30, 2022 | $1.15 | +62.0% |
| FY2021 | Jun 30, 2021 | $0.71 | – |
| FY2020 | Jun 30, 2020 | $0.00 | – |
| FY2019 | Jun 30, 2019 | $0.00 | – |
| FY2018 | Jun 30, 2018 | -$1.42 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $0.99 | +20.7% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $0.59 | -10.6% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $0.89 | +21.9% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $0.83 | +45.6% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $0.82 | +90.7% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $0.66 | +17.9% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $0.73 | +28.1% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $0.57 | +72.7% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $0.43 | +10.3% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $0.56 | +133.3% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $0.57 | -3.4% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $0.33 | -32.7% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $0.39 | +11.4% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $0.24 | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $0.59 | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $0.49 | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $0.35 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?